Kelly Leanne has filed 4 insider transactions across 1 company since September 2023.
Most recent transaction: a grant/award of 43222 shares of GRI Bio, Inc. ($GRI) on September 18, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 18, 2025 | GRI Bio, Inc. | $GRI | Kelly Leanne | Chief Financial Officer | A | Stock Option (Right to Buy) | 43222 | $0.00 | 43,222.0000 | 2,496,800 | 9999.99% | 1.73% |
| Aug. 26, 2025 | GRI Bio, Inc. | $GRI | Kelly Leanne | Chief Financial Officer | A | Stock Option (Right to Buy) | 11854 | $0.00 | 11,854.0000 | 2,496,800 | 9999.99% | 0.47% |
| Jan. 23, 2025 | GRI Bio, Inc. | $GRI | Kelly Leanne | Chief Financial Officer | A | Stock Option (Right to Buy) | 43319 | $0.69 | 43,319.0000 | 525,485 | 9999.99% | 8.24% |
| Sept. 22, 2023 | GRI Bio, Inc. | $GRI | Kelly Leanne | Chief Financial Officer | A | Stock Option (Right to Buy) | 83333 | $1.52 | 83,333.0000 | 646 | 9999.99% | 100.00% |